Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Thomas Mavrakanas, B.S. M.B.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Mavrakanas TA, Kamal O, Charytan DM. Prasugrel and Ticagrelor in Patients with Drug-Eluting Stents and Kidney Failure. Clin J Am Soc Nephrol. 2021 Apr 02. PMID: 33811128.
    Citations:    Fields:    
  2. Darbellay Farhoumand P, Berner A, Leszek A, Novotny-Court F, Koegler F, Mavrakanas T, Leidi A, Lister K, Carballo S, Reny JL. [Internal medicine in 2020]. Rev Med Suisse. 2021 Jan 20; 17(722):124-129. PMID: 33470568.
    Citations:    Fields:    Translation:Humans
  3. Barrelet I, Mavrakanas T, Carballo S. [Oral anticoagulation in chronic kidney disease]. Rev Med Suisse. 2021 Jan 20; 17(722):142-145. PMID: 33470571.
    Citations:    Fields:    Translation:Humans
  4. Roberts PR, Stromberg K, Johnson LC, Wiles BM, Mavrakanas TA, Charytan DM. A Systematic Review of the Incidence of Arrhythmias in Hemodialysis Patients Undergoing Long-Term Monitoring With Implantable Loop Recorders. Kidney Int Rep. 2021 Jan; 6(1):56-65. PMID: 33426385.
    Citations: 1     
  5. Cosimato C, Agoritsas T, Mavrakanas TA. Mineralocorticoid receptor antagonists in patients with chronic kidney disease. Pharmacol Ther. 2021 Mar; 219:107701. PMID: 33027644.
    Citations:    Fields:    
  6. Mavrakanas TA, Kamal O, Charytan DM. Cobalt alloy hip prostheses and new-onset heart failure in patients with and without chronic kidney disease. Clin Nephrol. 2020 10; 94(4):215-216. PMID: 32893814.
    Citations:    Fields:    
  7. Mavrakanas TA, Charytan DM, Winkelmayer WC. Direct oral anticoagulants in chronic kidney disease: an update. Curr Opin Nephrol Hypertens. 2020 09; 29(5):489-496. PMID: 32740218.
    Citations: 1     Fields:    Translation:Humans
  8. Mavrakanas TA, Charytan DM, Winkelmayer WC. Direct oral anticoagulants in chronic kidney disease: an update. Curr Opin Nephrol Hypertens. 2020 Jul 27. PMID: 32740159.
    Citations:    
  9. Mavrakanas TA, Garlo K, Charytan DM. Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1146-1154. PMID: 32444398.
    Citations: 3     Fields:    
  10. Ashley J, McArthur E, Bota S, Harel Z, Battistella M, Molnar AO, Jun M, Badve SV, Garg AX, Manuel D, Tanuseputro P, Wells P, Mavrakanas T, Rhodes E, Sood MM. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants. Am J Kidney Dis. 2020 09; 76(3):311-320. PMID: 32333946.
    Citations: 1     Fields:    Translation:Humans
  11. Mavrakanas TA, Giannetti N, Sapir-Pichhadze R, Alam A. Mineralocorticoid Receptor Antagonists and Renal Outcomes in Heart Failure Patients with and without Chronic Kidney Disease. Cardiorenal Med. 2020; 10(1):32-41. PMID: 31665724.
    Citations:    Fields:    
  12. Mavrakanas TA, Khattak A, Wang W, Singh K, Charytan DM. Association of Chronic Kidney Disease with Preserved Ejection Fraction Heart Failure Is Independent of Baseline Cardiac Function. Kidney Blood Press Res. 2019; 44(5):1247-1258. PMID: 31476759.
    Citations: 1     Fields:    Translation:Humans
  13. Mavrakanas TA, Lipman ML. Response to the Letter to the Editor From Dr Kawada, "Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus". Can J Diabetes. 2020 02; 44(1):5. PMID: 31582207.
    Citations:    Fields:    Translation:Humans
  14. Mavrakanas TA, Chatzizisis YS, Gariani K, Kereiakes DJ, Gargiulo G, Helft G, Gilard M, Feres F, Costa RA, Morice MC, Georges JL, Valgimigli M, Bhatt DL, Mauri L, Charytan DM. Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis. Clin J Am Soc Nephrol. 2019 06 07; 14(6):810-822. PMID: 31010936.
    Citations: 2     Fields:    Translation:Humans
  15. Mavrakanas TA, Asfour K, Vasilevsky M, Barré PE, Alam A. External validation of prediction models for mortality in an incident dialysis population?. Clin Nephrol. 2019 Feb; 91(2):65-71. PMID: 30526813.
    Citations:    Fields:    Translation:Humans
  16. Mavrakanas TA, Khattak A, Singh K, Charytan DM. Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD. BMC Nephrol. 2018 07 11; 19(1):176. PMID: 29996910.
    Citations: 2     Fields:    Translation:Humans
  17. Cooke AB, Ta V, Iqbal S, Gomez YH, Mavrakanas T, Barré P, Vasilevsky M, Rahme E, Daskalopoulou SS. The Impact of Intradialytic Pedaling Exercise on Arterial Stiffness: A Pilot Randomized Controlled Trial in a Hemodialysis Population. Am J Hypertens. 2018 03 10; 31(4):458-466. PMID: 29126178.
    Citations: 7     Fields:    Translation:Humans
  18. Mavrakanas TA, Sood MM. Direct Factor Xa Inhibitors for Long-term Stroke Prevention in Atrial Fibrillation: Could the Lower Dose Fit All? Can J Cardiol. 2018 05; 34(5):690.e15. PMID: 29731031.
    Citations:    Fields:    Translation:Humans
  19. Von Düring S, Mavrakanas T, Muller H, Primmaz S, Grosgurin O, Louis Simonet M, Marti C, Nendaz M, Serratrice J, Stirnemann J, Carballo S, Darbellay Farhoumand P. [Recent advances in internal medicine]. Rev Med Suisse. 2018 Jan 17; 14(590):140-144. PMID: 29341527.
    Citations:    Fields:    Translation:Humans
  20. Mavrakanas TA, Sniderman AD, Barré PE, Alam A. Serial versus single troponin measurements for the prediction of cardiovascular events and mortality in stable chronic haemodialysis patients. Nephrology (Carlton). 2018 Jan; 23(1):69-74. PMID: 27718506.
    Citations: 4     Fields:    Translation:HumansCells
  21. Mavrakanas TA, Lipman ML. Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers for the Treatment of Hypertension in Adults With Type 2 Diabetes: Why We Favour Angiotensin Receptor Blockers. Can J Diabetes. 2018 Apr; 42(2):118-123. PMID: 29602404.
    Citations: 1     Fields:    Translation:Humans
  22. Mavrakanas TA, Aurian-Blajeni DE, Charytan DM. Early versus late initiation of renal replacement therapy in patients with acute kidney injury: a meta-analysis of randomised clinical trials. Swiss Med Wkly. 2017; 147:w14507. PMID: 29039628.
    Citations: 5     Fields:    Translation:Humans
  23. Mavrakanas TA, Fournier MA, Clairoux S, Amiel JA, Tremblay ME, Vinh DC, Coursol C, Thirion DJG, Cantarovich M. Neutropenia in kidney and liver transplant recipients: Risk factors and outcomes. Clin Transplant. 2017 Oct; 31(10). PMID: 28736953.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  24. Mavrakanas TA, Khattak A, Singh K, Charytan DM. Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography. Clin J Am Soc Nephrol. 2017 Oct 06; 12(10):1624-1633. PMID: 28801528.
    Citations: 3     Fields:    Translation:Humans
  25. Mavrakanas TA, Alam A, Reny JL, Fontana P. Platelet reactivity in stable cardiovascular patients with chronic kidney disease. Platelets. 2018 Jul; 29(5):455-462. PMID: 28580812.
    Citations: 2     Fields:    Translation:HumansCells
  26. Mavrakanas TA, Samer CF, Nessim SJ, Frisch G, Lipman ML. Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients. J Am Soc Nephrol. 2017 Jul; 28(7):2241-2248. PMID: 28302754.
    Citations: 28     Fields:    Translation:Humans
  27. Mavrakanas TA, Charytan DM. Cardiovascular complications in chronic dialysis patients. Curr Opin Nephrol Hypertens. 2016 11; 25(6):536-544. PMID: 27636771.
    Citations: 8     Fields:    Translation:Humans
  28. Mavrakanas TA, Sniderman AD, Barré PE, Vasilevsky M, Alam A. High Ultrafiltration Rates Increase Troponin Levels in Stable Hemodialysis Patients. Am J Nephrol. 2016; 43(3):173-8. PMID: 27064739.
    Citations: 2     Fields:    Translation:Humans
  29. Gariani K, Mavrakanas T, Combescure C, Perrier A, Marti C. Is diabetes mellitus a risk factor for venous thromboembolism? A systematic review and meta-analysis of case-control and cohort studies. Eur J Intern Med. 2016 Mar; 28:52-8. PMID: 26507303.
    Citations: 10     Fields:    Translation:Humans
  30. Mavrakanas TA, Chatzizisis YS. Bivalirudin in ST-segment-elevation myocardial infarction: for better or worse? Expert Rev Cardiovasc Ther. 2015; 13(8):893-5. PMID: 26138859.
    Citations:    Fields:    Translation:Humans
  31. Mavrakanas TA, Chatzizisis YS. Bivalirudin in stable angina and acute coronary syndromes. Pharmacol Ther. 2015 Aug; 152:1-10. PMID: 25857452.
    Citations: 2     Fields:    Translation:HumansAnimals
  32. Mavrakanas TA, Samer C, Fontana P, Perrier A. Direct oral anticoagulants: efficacy and safety in patient subgroups. Swiss Med Wkly. 2015; 145:w14081. PMID: 25658756.
    Citations: 5     Fields:    Translation:Humans
  33. Mavrakanas TA, de Haller R, Philippe J. Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis. Can J Diabetes. 2015 Feb; 39(1):18-20. PMID: 25444679.
    Citations:    Fields:    Translation:Humans
  34. Carballo S, Lucker L, Mavrakanas T, John G, Felix P, Perrier A. [A review of hospital based internal medicine in 2013]. Rev Med Suisse. 2014 Jan 22; 10(414):171-2, 174-6. PMID: 24624734.
    Citations:    Fields:    Translation:Humans
  35. Mavrakanas TA, Gariani K, Martin PY. Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review. Eur J Intern Med. 2014 Feb; 25(2):173-6. PMID: 24315413.
    Citations: 23     Fields:    Translation:Humans
  36. Mavrakanas TA, Bouatou Y, Samer C, de Seigneux S, Meyer P. Carbimazole-induced, ANCA-associated, crescentic glomerulonephritis: case report and literature review. Ren Fail. 2013; 35(3):414-7. PMID: 23343442.
    Citations: 2     Fields:    Translation:Humans
  37. Mavrakanas TA, Lobrinus A, Berdagué P, Seebach JD, Reny JL. Severe mitral valve regurgitation in polymyositis. J Clin Rheumatol. 2012 Oct; 18(7):367-9. PMID: 23047538.
    Citations: 1     Fields:    Translation:Humans
  38. Tsirella E, Mavrakanas T, Rager O, Tsartsalis S, Kallaras K, Kokkas B, Mironidou-Tzouveleki M. Low dose pioglitazone does not affect bone formation and resorption markers or bone mineral density in streptozocin-induced diabetic rats. J Physiol Pharmacol. 2012 Apr; 63(2):201-4. PMID: 22653908.
    Citations: 6     Fields:    Translation:Animals
  39. Mavrakanas T, Bounameaux H. The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism. Pharmacol Ther. 2011 Apr; 130(1):46-58. PMID: 21185864.
    Citations: 22     Fields:    Translation:Humans
  40. Mavrakanas TA, Cheva A, Kallaras K, Karkavelas G, Mironidou-Tzouveleki M. Effect of ramipril alone compared to ramipril with eplerenone on diabetic nephropathy in streptozocin-induced diabetic rats. Pharmacology. 2010; 86(2):85-91. PMID: 20689340.
    Citations: 1     Fields:    Translation:Animals
  41. Mavrakanas TA, Tomos C, Pratsiou P, Seventekidou I, Tzouvelekis G. Transient glycosuria during a urinary tract infection. Presse Med. 2010 Jan; 39(1):145-6. PMID: 19846272.
    Citations:    Fields:    Translation:Humans
  42. Exiara T, Mavrakanas TA, Papazoglou L, Papazoglou D, Christakidis D, Maltezos E. A prospective study of acute poisonings in a sample of Greek patients. Cent Eur J Public Health. 2009 Sep; 17(3):158-60. PMID: 20020606.
    Citations: 8     Fields:    Translation:Humans
  43. Mavrakanas TA, Konsoula G, Patsonis I, Merkouris BP. Childhood obesity and elevated blood pressure in a rural population of northern Greece. Rural Remote Health. 2009 Apr-Jun; 9(2):1150. PMID: 19555129.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  44. Mavrakanas T, Frachebois C, Soualah A, Aloui F, Julier I, Bastide D. C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome. Presse Med. 2009 Oct; 38(10):1399-403. PMID: 19419831.
    Citations: 5     Fields:    Translation:Humans
  45. Mavrakanas T, Bastide D. [C-peptide: a by-product of insulin biosynthesis or an active peptide hormone?]. Presse Med. 2009 Jan; 38(1):68-72. PMID: 18951760.
    Citations:    Fields:    Translation:HumansAnimalsCells
  46. Mandalos AT, Peios DK, Mavrakanas TA, Golias VA, Megalou KG, Delidou KA, Gregoriadou AC, Katsougiannopoulos BC. Prevalence of astigmatism among students in northern Greece. Eur J Ophthalmol. 2002 Jan-Feb; 12(1):1-4. PMID: 11936436.
    Citations: 2     Fields:    Translation:Humans
  47. Mavrakanas TA, Mandalos A, Peios D, Golias V, Megalou K, Gregoriadou A, Delidou K, Katsougiannopoulos B. Prevalence of myopia in a sample of Greek students. Acta Ophthalmol Scand. 2000 12; 78(6):656-9. PMID: 11167226.
    Citations: 10     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mavrakanas's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (198)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.